(Q44001504)

English

Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).

scientific article published on 15 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC). (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Michela de Martino

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tobias Klatte

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Christoph Seemann

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Matthias Waldert

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Andrea Haitel

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Georg Schatzl

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mesut Remzi

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Peter Weibl

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

15 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

E348-53

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

EAU guidelines on renal cell carcinoma: the 2010 update

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Neoadjuvant and adjuvant treatment of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Integration of surgery and systemic therapy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Surveillance for renal cell carcinoma: why and how? When and how often?

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Prognostic factors and predictive models in renal cell carcinoma: a contemporary review

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12067

21 January 2018

Identifiers

10.1111/BJU.12067

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

release_bsyb5frrifarhkymctfkgweify

1 reference

https://api.fatcat.wiki/v0/release/bsyb5frrifarhkymctfkgweify

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44001504&oldid=2105542708"